pmid,title,journal,year,drug,disease
40573371,"Risk Factors for Seeking Medical Care Following Nirmatrelvir-Ritonavir (Paxlovid) Treatment for COVID-19: ""Symptom Rebound"".",Viruses,2025,Paxlovid,Chronic Obstructive Pulmonary Disease
39841477,Sex Differences in Long COVID.,JAMA network open,2025,Paxlovid,Chronic Obstructive Pulmonary Disease
37387690,"Oral Nirmatrelvir and Ritonavir for Coronavirus Disease 2019 in Vaccinated, Nonhospitalized Adults Aged 18-50 Years.",Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,2023,Paxlovid,Chronic Obstructive Pulmonary Disease
